CARD15/NOD2 Polyclonal Antibody, AbBy Fluor-594 Conjugated, BF594, Rabbit

Catalog Number: BSS-BS-7084R-BF594
Article Name: CARD15/NOD2 Polyclonal Antibody, AbBy Fluor-594 Conjugated, BF594, Rabbit
Biozol Catalog Number: BSS-BS-7084R-BF594
Supplier Catalog Number: bs-7084R-BF594
Alternative Catalog Number: BSS-BS-7084R-BF594-100
Manufacturer: Bioss
Host: Rabbit
Category: Antikörper
Application: FC, WB
Species Reactivity: Human
Conjugation: BF594
Alternative Names: ACUG, Arthrocutaneouveal granulomatosis, BLAU, CARD15, Caspase recruitment domain protein 15, Caspase recruitment domain-containing protein 15, IBD1, Inflammatory bowel disease protein 1, LRR containing protein, LRR-containing protein, Nod2, NOD2 protein, NOD2_HUMAN, NOD2B, nucleotide binding oligomerization domain 2, nucleotide-binding oligomerization domain 2, Nucleotide-binding oligomerization domain-containing protein 2, PSORAS1.
Defects in NOD2 are the cause of sarcoidosis early-onset (EOS) . EOS is a form of sarcoidosis manifesting in children younger than 4 years of age. Sarcoidosis is an idiopathic, systemic, inflammatory disease characterized by the formation of immune granulomas in involved organs. Granulomas predominantly invade the lungs and the lymphatic system, but also skin, liver, spleen, eyes and other organs may be involved. Early-onset sarcoidosis is quite rare and has a distinct triad of skin, joint and eye disorders, without apparent pulmonary involvement. Compared with an asymptomatic and sometimes naturally disappearing course of the disease in older children, early-onset sarcoidosis is progressive and in many cases causes severe complications, such as blindness, joint destruction and visceral involvement.
Clonality: Polyclonal
Concentration: 1ug/ul
NCBI: 64127
UniProt: Q9HC29
Buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Source: KLH conjugated synthetic peptide derived from human CARD15
Target: CARD15/NOD2
Application Dilute: WB(1:300-5000), FCM(1:20-100)